Titan Pharmaceuticals Inc. (TTNP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Titan Pharmaceuticals Inc...

    NASDAQ: TTNP · Real-Time Price · USD
    4.08
    0.00 (0.00%)
    At close: Sep 09, 2025, 12:21 PM

    Titan Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 1K 60K 1.53M
    Cost of Revenue
    		 5K n/a 196K 199K
    Gross Profit
    		 -5K 1K -136K 1.33M
    Operating Income
    		 -4.56M -7.28M -10.23M -9.35M
    Interest Income
    		 1K 5K 53K 1K
    Pretax Income
    		 -4.71M -5.57M -10.21M -8.78M
    Net Income
    		 -4.71M -5.57M -10.18M -8.11M
    Selling & General & Admin
    		 4.56M 5.55M 6.03M 4.99M
    Research & Development
    		 n/a 1.91M 4.76M 5.69M
    Other Expenses
    		 n/a -183K -497K -84K
    Operating Expenses
    		 4.56M 7.28M 10.29M 10.68M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 4.56M 7.46M 10.29M 10.88M
    Income Tax Expense
    		 n/a n/a -29K -662K
    Shares Outstanding (Basic)
    		 899K 752K 671.7K 2M
    Shares Outstanding (Diluted)
    		 899K 752K 671.7K 2M
    EPS (Basic)
    		 -5.23 -7.41 -15.15 -4.06
    EPS (Diluted)
    		 -5.23 -7.41 -15.15 -4.06
    EBITDA
    		 -4.7M -7.17M -10.04M -9.13M
    EBIT
    		 -4.71M -7.28M -10.23M -9.35M
    Depreciation & Amortization
    		 5K 112K 196K 221K

    Add to Watchlist